Total Funding
86
52
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
226074
Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.
Cameron Jones: Chief Financial Officer- David Foster: President, and Founder
About the Company
Isla Pharmaceuticals is a biotechnology company that has a rapid and efficient development strategy to develop tropical disease therapies. Isla Pharmaceuticals' range of offerings includes the development of treatment of dengue infection and other mosquito-borne illnesses, enabling physicians to treat diseases like malaria easily.
